Natural Product: NPC105731

Natural Product IDNPC105731
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
ZJELZQKROOYPAX-UHFFFAOYSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 545613
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0003909] Fatty Acyls
        • [CHEMONTID:0000324] Fatty acid esters

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey ZJELZQKROOYPAX-UHFFFAOYSA-N
Standard InCHI InChI=1S/C36H72O3/c1-3-5-7-9-11-13-15-17-18-19-21-23-25-27-29-31-33-38-34-35-39-36(37)32-30-28-26-24-22-20-16-14-12-10-8-6-4-2/h3-35H2,1-2H3
SMILES CCCCCCCCCCCCCCCCCCOCCOC(=O)CCCCCCCCCCCCCCC

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   552.55 Volume:   654.946
?
Van der Waals volume.
Dense:   0.844 LogP:   8.309
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   4.688
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -7.94
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   35.0 Rigid Bonds:   1.0
TPSA:   35.53
?
Topological Polar Surface Area.
H-Bond Acceptor:   3.0
H-Bond Donor:   0.0 Rings:   0.0
Heavy Atoms:   3.0

MedChem Properties

QED Drug-Likeness Score:   0.059 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.128 Fsp3:   0.972
MCE-18:   0.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.6 Fluc inhibitor:   0.286
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.001
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.019
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.99 Promiscuous compounds:   0.079

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.134 MDCK Permeability:   -4.929
Pgp-inhibitor:   0.0 Pgp-substrate:   0.09
PAMPA:   0.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.995
20% Bioavailability (F20%):   0.999 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   0.995

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.001 MRP1:   0.997
Plasma Protein Binding (PPB):   104.286% Volume Distribution (VD):   2.718
Fu: 0.127%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.231
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.995
BSEP inhibitor:   0.981

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   1.0
CYP2C19-inhibitor:   0.001 CYP2C19-substrate:   0.318
CYP2C9-inhibitor:   0.912 CYP2C9-substrate:   0.53
CYP2D6-inhibitor:   0.943 CYP2D6-substrate:   0.329
CYP3A4-inhibitor:   0.001 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.086 CYP2C8-inhibitor:   1.0
HLM stability:   0.088
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  4.593 Half-life (T1/2):  3.297

ADMET: Toxicity

hERG Blockers:  0.929 hERG Blockers (10um):  0.977
Human Hepatotoxicity (H-HT):  0.31 Drug-induced Liver Injury (DILI):  0.046
AMES Toxicity:  0.007 Rat Oral Acute Toxicity:  0.058
Maximum Recommended Daily Dose:  0.112 Skin Sensitization:  0.999
Carcinogencity:  0.299 Eye Corrosion:  0.987
Eye Irritation:  0.99 Respiratory Toxicity:  0.979
Drug-induced Neurotoxicity:  0.002 Ototoxicity:  0.107
Hematotoxicity:  0.036 Drug-induced Nephrotoxicity:  0.181
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.06
A549 Cytotoxicity:  0.917 Hek293 Cytotoxicity:  0.292
BCF:   -0.31
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   5.402
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.939
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.04
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO10903 Sinopodophyllum hexandrum Species Berberidaceae Eukaryota n.a. n.a. n.a. PMID[26359402]
NPO10903 Sinopodophyllum hexandrum Species Berberidaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO10903 Sinopodophyllum hexandrum Species Berberidaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO10903 Sinopodophyllum hexandrum Species Berberidaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC105731 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7097 Intermediate Similarity NPC149299
0.6774 Remote Similarity NPC80396
0.625 Remote Similarity NPC154642
0.625 Remote Similarity NPC80641
0.625 Remote Similarity NPC603612
0.6129 Remote Similarity NPC223249
0.5938 Remote Similarity NPC154396
0.5806 Remote Similarity NPC250028
0.5806 Remote Similarity NPC236579
0.5806 Remote Similarity NPC80234
0.5806 Remote Similarity NPC203531
0.5806 Remote Similarity NPC256163
0.5806 Remote Similarity NPC40597
0.5556 Remote Similarity NPC152008
0.5556 Remote Similarity NPC605028
0.5455 Remote Similarity NPC286695
0.5429 Remote Similarity NPC26253
0.5312 Remote Similarity NPC86545
0.5312 Remote Similarity NPC286498
0.5312 Remote Similarity NPC223374
0.5312 Remote Similarity NPC196442
0.5312 Remote Similarity NPC301398
0.5312 Remote Similarity NPC608162
0.5312 Remote Similarity NPC609004
0.5278 Remote Similarity NPC488257
0.5278 Remote Similarity NPC469937
0.5278 Remote Similarity NPC94699
0.5278 Remote Similarity NPC320588
0.5278 Remote Similarity NPC53463
0.5263 Remote Similarity NPC223677
0.5172 Remote Similarity NPC99700
0.5161 Remote Similarity NPC53541
0.5152 Remote Similarity NPC322892
0.5152 Remote Similarity NPC12904
0.5152 Remote Similarity NPC476550
0.5143 Remote Similarity NPC310746
0.5143 Remote Similarity NPC223675
0.5143 Remote Similarity NPC68577
0.5135 Remote Similarity NPC163345
0.5135 Remote Similarity NPC71761

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC105731 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5556 Remote Similarity NPD7536 Phase 4
0.5385 Remote Similarity NPD631 Phase 4
0.525 Remote Similarity NPD630 Approved

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data